FLUDARABINE PHOSPHATE

FLUDARABINE PHOSPHATE was reported 39838 times

FLUDARABINE PHOSPHATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 PRE-ENGRAFTMENT IMMUNE REACTION 65 0.8125
1 ADENOVIRUS REACTIVATION 105 0.7292
2 MENINGOMYELITIS HERPES 20 0.6250
3 CYTOKINE INCREASED 69 0.5111
4 CHIMERISM 40 0.4494
5 PROTOTHECOSIS 41 0.4362
6 VIRAL HAEMORRHAGIC CYSTITIS 300 0.4213
7 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 1164 0.4207
8 CYSTITIS VIRAL 161 0.4204
9 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 584 0.4133
10 MALIGNANT GENITOURINARY TRACT NEOPLASM 27 0.4030
11 JUVENILE CHRONIC MYELOMONOCYTIC LEUKAEMIA 20 0.3922
12 ENGRAFTMENT SYNDROME 208 0.3519
13 IDIOPATHIC PNEUMONIA SYNDROME 104 0.3490
14 HUMAN HERPESVIRUS 6 ENCEPHALITIS 98 0.3451
15 VIRURIA 37 0.3426
16 CHRONIC LYMPHOCYTIC LEUKAEMIA RECURRENT 237 0.3400
17 AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME 20 0.3390
18 ACUTE GRAFT VERSUS HOST DISEASE 1538 0.3357
19 ENCEPHALITIS CYTOMEGALOVIRUS 147 0.3356
20 ACUTE GRAFT VERSUS HOST DISEASE IN LIVER 237 0.3296
21 BONE MARROW TRANSPLANT REJECTION 72 0.3273
22 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 691 0.3244
23 CHRONIC GRAFT VERSUS HOST DISEASE IN INTESTINE 61 0.3211
24 CHRONIC GRAFT VERSUS HOST DISEASE IN SKIN 295 0.3186
25 GRAFT VERSUS HOST DISEASE IN SKIN 695 0.3152
26 AUTOIMMUNE PANCYTOPENIA 27 0.2967
27 CORD BLOOD TRANSPLANT THERAPY 25 0.2941
28 ADENOVIRAL HEPATITIS 69 0.2936
29 CYTOMEGALOVIRUS INFECTION REACTIVATION 1292 0.2922
30 DISSEMINATED TOXOPLASMOSIS 35 0.2917
31 ADENOVIRUS INFECTION 840 0.2894
32 RETINITIS VIRAL 35 0.2893
33 GASTROENTERITIS ASTROVIRAL 23 0.2875
34 CHRONIC GRAFT VERSUS HOST DISEASE IN EYE 58 0.2857
35 BLOOD STEM CELL TRANSPLANT FAILURE 60 0.2791
36 ENGRAFT FAILURE 80 0.2787
37 CHRONIC LYMPHOCYTIC LEUKAEMIA TRANSFORMATION 58 0.2775
38 IMMUNE EFFECTOR CELL-ASSOCIATED HAEMATOTOXICITY 48 0.2759
39 BRONCHIOLITIS OBLITERANS SYNDROME 47 0.2686
40 EPSTEIN-BARR VIRUS INFECTION REACTIVATION 346 0.2627
41 CHRONIC GRAFT VERSUS HOST DISEASE 942 0.2607
42 CHRONIC GRAFT VERSUS HOST DISEASE ORAL 61 0.2490
43 CHRONIC GRAFT VERSUS HOST DISEASE IN LUNG 43 0.2486
44 STENOTROPHOMONAS SEPSIS 30 0.2479
45 ADENOVIRAL HAEMORRHAGIC CYSTITIS 51 0.2452
46 HUMAN HERPESVIRUS 6 INFECTION 460 0.2431
47 PARAINFLUENZA VIRUS INFECTION 25 0.2427
48 EPSTEIN-BARR VIRAEMIA 268 0.2417
49 GASTROENTERITIS ADENOVIRUS 37 0.2357
50 CHRONIC GRAFT VERSUS HOST DISEASE IN LIVER 85 0.2335
51 GRAFT VERSUS HOST DISEASE IN EYE 51 0.2208
52 LEUKOERYTHROBLASTOSIS 22 0.2200
53 OUT OF SPECIFICATION TEST RESULTS 22 0.2200
54 BK POLYOMAVIRUS TEST POSITIVE 21 0.2188
55 BK VIRUS INFECTION 725 0.2148
56 CHRONIC LYMPHOCYTIC LEUKAEMIA REFRACTORY 20 0.2128
57 HUMAN HERPESVIRUS 6 INFECTION REACTIVATION 71 0.2023
58 MENINGITIS TUBERCULOUS 113 0.2021
59 ACUTE MYELOID LEUKAEMIA RECURRENT 430 0.2001
60 GRAFT VERSUS HOST DISEASE IN LIVER 143 0.1997
61 GEOTRICHUM INFECTION 42 0.1991
62 MICROSPORIDIA INFECTION 69 0.1966
63 GRAFT VERSUS HOST DISEASE IN INTESTINE 25 0.1923
64 B-CELL APLASIA 49 0.1899
65 HERPES SIMPLEX PNEUMONIA 24 0.1890
66 FUSARIUM INFECTION 128 0.1829
67 PNEUMONIA ADENOVIRAL 35 0.1768
68 BLOOD STEM CELL HARVEST FAILURE 26 0.1757
69 VENOOCCLUSIVE LIVER DISEASE 865 0.1750
70 GRAFT VERSUS HOST DISEASE 1248 0.1734
71 CONGENITAL APLASIA 53 0.1704
72 VENOOCCLUSIVE DISEASE 426 0.1700
73 CYSTITIS HAEMORRHAGIC 678 0.1680
74 ALLOGENIC STEM CELL TRANSPLANTATION 26 0.1646
75 CAR T-CELL-RELATED ENCEPHALOPATHY SYNDROME 20 0.1613
76 TRANSPLANT FAILURE 394 0.1606
77 CYTOKINE RELEASE SYNDROME 3015 0.1501
78 AUTOIMMUNE NEUTROPENIA 43 0.1488
79 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 854 0.1440
80 ENCEPHALITIS VIRAL 173 0.1420
81 ACUTE MYELOID LEUKAEMIA REFRACTORY 24 0.1395
82 HUMAN POLYOMAVIRUS INFECTION 74 0.1394
83 5Q MINUS SYNDROME 22 0.1375
84 UPPER RESPIRATORY FUNGAL INFECTION 26 0.1368
85 CEREBRAL TOXOPLASMOSIS 126 0.1349
86 CYTOMEGALOVIRUS VIRAEMIA 586 0.1316
87 SYSTEMIC MYCOSIS 152 0.1301
88 VIRAEMIA 178 0.1284
89 DISSEMINATED MUCORMYCOSIS 50 0.1269
90 HERPES ZOSTER INFECTION NEUROLOGICAL 20 0.1258
91 HYPOGAMMAGLOBULINAEMIA 810 0.1232
92 ENTEROCOLITIS VIRAL 37 0.1217
93 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 301 0.1165
94 TOXOPLASMOSIS 124 0.1148
95 LEUKAEMIA RECURRENT 193 0.1141
96 INFECTION REACTIVATION 130 0.1135
97 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 575 0.1129
98 JC VIRUS INFECTION 179 0.1119
99 EPSTEIN-BARR VIRUS INFECTION 682 0.1091
100 GRAFT VERSUS HOST DISEASE IN LUNG 52 0.1088
101 SHORT STATURE 28 0.1069
102 ENTEROCOCCAL BACTERAEMIA 113 0.1066
103 SPINAL INSTABILITY 27 0.1063
104 MANTLE CELL LYMPHOMA RECURRENT 46 0.1057
105 MINIMAL RESIDUAL DISEASE 50 0.1035
106 CYTOMEGALOVIRUS INFECTION 1692 0.1017
107 PNEUMONIA CYTOMEGALOVIRAL 197 0.1013
108 POLYOMAVIRUS VIRAEMIA 106 0.0998
109 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 170 0.0961
110 KLEBSIELLA SEPSIS 108 0.0958
111 HERPES ZOSTER REACTIVATION 25 0.0954
112 MENINGOENCEPHALITIS HERPETIC 41 0.0915
113 GASTROENTERITIS ROTAVIRUS 28 0.0909
114 GRAFT COMPLICATION 53 0.0903
115 ALPHA HAEMOLYTIC STREPTOCOCCAL INFECTION 82 0.0886
116 CYTOMEGALOVIRUS CHORIORETINITIS 173 0.0886
117 B-CELL TYPE ACUTE LEUKAEMIA 65 0.0886
118 COMPLICATIONS OF BONE MARROW TRANSPLANT 31 0.0859
119 ENTEROBACTER BACTERAEMIA 26 0.0858
120 CHLOROMA 36 0.0853
121 CEREBRAL ASPERGILLOSIS 52 0.0846
122 OBLITERATIVE BRONCHIOLITIS 111 0.0845
123 PARVOVIRUS INFECTION 33 0.0817
124 VIRAL DIARRHOEA 28 0.0814
125 CRYPTOSPORIDIOSIS INFECTION 42 0.0800
126 STENOTROPHOMONAS INFECTION 108 0.0796
127 PNEUMONIA RESPIRATORY SYNCYTIAL VIRAL 67 0.0795
128 LEUKAEMIC INFILTRATION EXTRAMEDULLARY 20 0.0784
129 MUCOSAL TOXICITY 21 0.0775
130 PARAINFLUENZAE VIRUS INFECTION 118 0.0775
131 CYTOMEGALOVIRUS HEPATITIS 27 0.0763
132 THROMBOTIC MICROANGIOPATHY 741 0.0760
133 ENTEROCOCCAL SEPSIS 61 0.0753
134 SCEDOSPORIUM INFECTION 53 0.0751
135 RHINOCEREBRAL MUCORMYCOSIS 26 0.0749
136 KLEBSIELLA BACTERAEMIA 71 0.0747
137 AUTOIMMUNE HAEMOLYTIC ANAEMIA 255 0.0743
138 VARICELLA ZOSTER VIRUS INFECTION 153 0.0737
139 REFRACTORY ANAEMIA WITH AN EXCESS OF BLASTS 23 0.0735
140 DIFFUSE LARGE B-CELL LYMPHOMA STAGE IV 24 0.0732
141 ENTEROBACTER SEPSIS 27 0.0730
142 ALTERNARIA INFECTION 27 0.0726
143 CITROBACTER INFECTION 31 0.0723
144 MYELOID LEUKAEMIA 36 0.0719
145 PREMATURE MENOPAUSE 66 0.0714
146 MALIGNANT TRANSFORMATION 32 0.0713
147 UREAPLASMA INFECTION 29 0.0711
148 DISSEMINATED BACILLUS CALMETTE-GUERIN INFECTION 33 0.0707
149 CYTOMEGALOVIRUS TEST POSITIVE 124 0.0695
150 FUNGAEMIA 109 0.0692
151 BACTERIAL SEPSIS 225 0.0690
152 ENCEPHALITIS HERPES 34 0.0688
153 SYSTEMIC CANDIDA 172 0.0684
154 CORONA VIRUS INFECTION 29 0.0674
155 BRONCHOPULMONARY ASPERGILLOSIS 518 0.0667
156 MYELODYSPLASTIC SYNDROME 963 0.0665
157 CAMPYLOBACTER INFECTION 55 0.0662
158 TOXIC LEUKOENCEPHALOPATHY 48 0.0661
159 HERPES SIMPLEX REACTIVATION 25 0.0656
160 ASPERGILLUS TEST POSITIVE 20 0.0649
161 PULMONARY MUCORMYCOSIS 34 0.0644
162 GROWTH FAILURE 22 0.0640
163 PARVOVIRUS B19 INFECTION 57 0.0637
164 CANDIDA SEPSIS 57 0.0635
165 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 524 0.0635
166 MUCORMYCOSIS 165 0.0634
167 BLADDER HYPERTROPHY 28 0.0633
168 PSEUDOMONAL SEPSIS 111 0.0633
169 FUNGAL SEPSIS 52 0.0626
170 STEM CELL TRANSPLANT 155 0.0620
171 TRANSPLANTATION COMPLICATION 26 0.0619
172 CYTOMEGALOVIRUS ENTERITIS 22 0.0618
173 PNEUMONIA FUNGAL 244 0.0618
174 CENTRAL NERVOUS SYSTEM LEUKAEMIA 24 0.0611
175 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 447 0.0595
176 B-CELL LYMPHOMA RECURRENT 32 0.0589
177 STREPTOCOCCAL BACTERAEMIA 64 0.0588
178 POLYSEROSITIS 25 0.0587
179 APLASIA 115 0.0587
180 ASPERGILLUS INFECTION 385 0.0586
181 APLASTIC ANAEMIA 304 0.0581
182 ANAEMIA HAEMOLYTIC AUTOIMMUNE 46 0.0556
183 MUCOSAL INFLAMMATION 1439 0.0549
184 SINUSITIS FUNGAL 44 0.0549
185 DIFFUSE LARGE B-CELL LYMPHOMA RECURRENT 119 0.0539
186 AUTOIMMUNE THROMBOCYTOPENIA 23 0.0531
187 INTERLEUKIN LEVEL INCREASED 29 0.0525
188 RHINOVIRUS INFECTION 202 0.0518
189 HERPES SIMPLEX 336 0.0516
190 HISTIOCYTOSIS HAEMATOPHAGIC 153 0.0515
191 CHRONIC LYMPHOCYTIC LEUKAEMIA 244 0.0514
192 CYTOPENIA 627 0.0512
193 BLOOD FOLLICLE STIMULATING HORMONE INCREASED 20 0.0512
194 ACUTE MYELOID LEUKAEMIA 792 0.0508
195 CAPILLARY LEAK SYNDROME 103 0.0498
196 SECONDARY IMMUNODEFICIENCY 60 0.0494
197 BLINDNESS CORTICAL 24 0.0490
198 DIFFUSE LARGE B-CELL LYMPHOMA 377 0.0489
199 HYPERFERRITINAEMIA 21 0.0487
200 SERRATIA INFECTION 36 0.0483
201 PSEUDOMONAL BACTERAEMIA 41 0.0480
202 ASPERGILLOSIS 62 0.0474
203 TRANSFORMATION TO ACUTE MYELOID LEUKAEMIA 31 0.0473
204 STAPHYLOCOCCAL BACTERAEMIA 204 0.0469
205 ENTEROVIRUS INFECTION 40 0.0463
206 CELLULITIS STAPHYLOCOCCAL 30 0.0461
207 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 440 0.0460
208 ENTEROCOCCAL INFECTION 222 0.0459
209 ESCHERICHIA SEPSIS 133 0.0458
210 RESPIRATORY TRACT INFECTION FUNGAL 24 0.0455
211 STAPHYLOCOCCAL SEPSIS 222 0.0449
212 TRANSPLANT DYSFUNCTION 80 0.0448
213 EVANS SYNDROME 22 0.0446
214 CHRONIC MYELOID LEUKAEMIA RECURRENT 24 0.0439
215 CYTOKINE STORM 30 0.0438
216 MICROANGIOPATHY 41 0.0436
217 FEBRILE NEUTROPENIA 2871 0.0432
218 GASTROENTERITIS NOROVIRUS 57 0.0429
219 EPSTEIN-BARR VIRUS TEST POSITIVE 27 0.0428
220 THERAPY RESPONDER 21 0.0428
221 LEUKOENCEPHALOPATHY 159 0.0427
222 NEUROTOXICITY 741 0.0422
223 DIFFUSE LARGE B-CELL LYMPHOMA REFRACTORY 40 0.0422
224 MYELOPROLIFERATIVE NEOPLASM 28 0.0422
225 ROTAVIRUS INFECTION 24 0.0417
226 LOWER RESPIRATORY TRACT INFECTION VIRAL 21 0.0415
227 CYTOMEGALOVIRUS COLITIS 95 0.0413
228 BACTERAEMIA 489 0.0412
229 CORYNEBACTERIUM INFECTION 22 0.0411
230 METAPNEUMOVIRUS INFECTION 32 0.0408
231 NEUTROPENIC INFECTION 39 0.0408
232 PULMONARY VENO-OCCLUSIVE DISEASE 28 0.0400
233 NOROVIRUS INFECTION 57 0.0395
234 DIFFUSE ALVEOLAR DAMAGE 45 0.0391
235 ESCHERICHIA BACTERAEMIA 92 0.0391
236 DYSBIOSIS 32 0.0390
237 ACUTE LYMPHOCYTIC LEUKAEMIA 104 0.0367
238 DYSPLASIA 44 0.0367
239 TUMOUR FLARE 25 0.0366
240 BACILLUS INFECTION 23 0.0364
241 BLOOD FIBRINOGEN DECREASED 41 0.0359
242 N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED 50 0.0356
243 PNEUMATOSIS INTESTINALIS 101 0.0354
244 GENE MUTATION 70 0.0353
245 PNEUMONIA KLEBSIELLA 65 0.0353
246 STEROID DEPENDENCE 31 0.0353
247 PNEUMOCOCCAL SEPSIS 23 0.0350
248 PSEUDOMONAS INFECTION 299 0.0348
249 BONE MARROW FAILURE 705 0.0347
250 KLEBSIELLA INFECTION 175 0.0346
251 HAEMATOLOGICAL INFECTION 83 0.0339
252 HYPERLEUKOCYTOSIS 30 0.0339
253 PERIPHERAL T-CELL LYMPHOMA UNSPECIFIED 20 0.0337
254 SECOND PRIMARY MALIGNANCY 279 0.0335
255 MULTIPLE ORGAN DYSFUNCTION SYNDROME 931 0.0328
256 PNEUMOCYSTIS JIROVECII INFECTION 39 0.0326
257 LYMPHOPROLIFERATIVE DISORDER 95 0.0323
258 PULMONARY MYCOSIS 25 0.0321
259 STREPTOCOCCAL SEPSIS 37 0.0312
260 NEUTROPENIC COLITIS 64 0.0309
261 T-LYMPHOCYTE COUNT DECREASED 21 0.0308
262 BLOOD IMMUNOGLOBULIN G DECREASED 76 0.0306
263 BONE MARROW TRANSPLANT 58 0.0306
264 HEPATOSPLENOMEGALY 78 0.0304
265 ENCEPHALITIS 210 0.0303
266 HEPATITIS VIRAL 24 0.0299
267 PNEUMONIA PSEUDOMONAL 45 0.0293
268 HEPATITIS B REACTIVATION 92 0.0290
269 LYMPHOCYTE COUNT DECREASED 510 0.0288
270 HEPATITIS E 45 0.0285
271 SKIN TOXICITY 157 0.0278
272 MYELITIS 43 0.0277
273 ENTEROBACTER INFECTION 46 0.0273
274 DEMYELINATING POLYNEUROPATHY 28 0.0272
275 IMMUNE THROMBOCYTOPENIA 124 0.0271
276 PNEUMONIA INFLUENZAL 32 0.0269
277 MENINGITIS CRYPTOCOCCAL 47 0.0269
278 CENTRAL NERVOUS SYSTEM INFECTION 30 0.0262
279 LYMPHOPENIA 370 0.0261
280 LYMPHADENITIS 63 0.0260
281 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 99 0.0259
282 SQUAMOUS CELL CARCINOMA OF SKIN 156 0.0258
283 TUMOUR LYSIS SYNDROME 226 0.0257
284 NEPHROPATHY TOXIC 288 0.0256
285 NEUTROPENIC SEPSIS 182 0.0255
286 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 67 0.0252
287 PANCYTOPENIA 1408 0.0252
288 MUCOSAL DISORDER 25 0.0252
289 CLOSTRIDIUM DIFFICILE COLITIS 265 0.0250
290 MYCOBACTERIAL INFECTION 43 0.0249
291 HERPES ZOSTER DISSEMINATED 20 0.0249
292 PNEUMONIA VIRAL 79 0.0248
293 IMMUNE THROMBOCYTOPENIC PURPURA 70 0.0247
294 SOFT TISSUE INFECTION 45 0.0246
295 NEOPLASM RECURRENCE 83 0.0245
296 PULMONARY HAEMORRHAGE 191 0.0244
297 MYELOPATHY 46 0.0242
298 HYPOFIBRINOGENAEMIA 24 0.0242
299 APLASIA PURE RED CELL 83 0.0241
300 LUNG CONSOLIDATION 67 0.0239
301 POLYOMAVIRUS-ASSOCIATED NEPHROPATHY 56 0.0239
302 SERUM FERRITIN INCREASED 126 0.0239
303 FEBRILE INFECTION 28 0.0238
304 TUMOUR PSEUDOPROGRESSION 26 0.0237
305 POLYMYOSITIS 42 0.0237
306 BONE MARROW TOXICITY 28 0.0236
307 PNEUMONIA STAPHYLOCOCCAL 46 0.0233
308 PAROTITIS 27 0.0233
309 PLASMA CELL MYELOMA REFRACTORY 31 0.0232
310 GROWTH RETARDATION 68 0.0231
311 NEUROLOGICAL DECOMPENSATION 53 0.0229
312 BLOOD CULTURE POSITIVE 68 0.0227
313 DEVICE RELATED SEPSIS 45 0.0223
314 CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY 32 0.0223
315 LIP ULCERATION 26 0.0222
316 RENAL TUBULAR INJURY 27 0.0222
317 TRANSPLANT REJECTION 176 0.0219
318 IMMUNOGLOBULINS DECREASED 30 0.0218
319 PULMONARY ALVEOLAR HAEMORRHAGE 122 0.0217
320 ESCHERICHIA INFECTION 178 0.0216
321 NEUROENDOCRINE CARCINOMA OF THE SKIN 21 0.0215
322 IRON OVERLOAD 23 0.0213
323 GASTROINTESTINAL VIRAL INFECTION 22 0.0211
324 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 103 0.0206
325 MUCOUS MEMBRANE DISORDER 28 0.0205
326 GLOMERULONEPHRITIS MEMBRANOUS 24 0.0204
327 HAEMOPHILUS INFECTION 20 0.0204
328 PNEUMOCYSTIS JIROVECII PNEUMONIA 204 0.0203
329 HAEMATOTOXICITY 193 0.0203
330 PARAPARESIS 36 0.0202
331 KIDNEY FIBROSIS 35 0.0202
332 SEPTIC SHOCK 873 0.0200
333 HAEMATOLOGICAL MALIGNANCY 57 0.0200
334 BRAIN ABSCESS 50 0.0197
335 PNEUMOCYSTIS JIROVECI PNEUMONIA 44 0.0197
336 ACUTE RESPIRATORY DISTRESS SYNDROME 349 0.0197
337 MENINGITIS BACTERIAL 28 0.0196
338 NOCARDIOSIS 50 0.0195
339 HYPOALBUMINAEMIA 151 0.0194
340 LYMPHOCYTOSIS 41 0.0190
341 VARICELLA 45 0.0188
342 GASTROINTESTINAL TOXICITY 90 0.0187
343 HEPATITIS B 111 0.0184
344 ORGANISING PNEUMONIA 91 0.0183
345 ACINETOBACTER INFECTION 20 0.0183
346 PNEUMONIA STREPTOCOCCAL 20 0.0182
347 BACTERIAL INFECTION 339 0.0182
348 MULTI-ORGAN FAILURE 311 0.0180
349 B-CELL LYMPHOMA 61 0.0179
350 CYTOGENETIC ABNORMALITY 20 0.0177
351 PNEUMONIA BACTERIAL 162 0.0176
352 MENINGITIS VIRAL 24 0.0175
353 RESPIRATORY SYNCYTIAL VIRUS INFECTION 152 0.0174
354 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 106 0.0174
355 MUCOSAL HAEMORRHAGE 20 0.0172
356 MANTLE CELL LYMPHOMA 26 0.0171
357 NON-HODGKIN'S LYMPHOMA 22 0.0168
358 LYMPHOMA 257 0.0166
359 PNEUMOMEDIASTINUM 30 0.0166
360 FEBRILE BONE MARROW APLASIA 70 0.0165
361 H1N1 INFLUENZA 23 0.0164
362 HERPES VIRUS INFECTION 94 0.0163
363 URINARY TRACT INFECTION BACTERIAL 41 0.0162
364 DISSEMINATED TUBERCULOSIS 41 0.0160
365 GUILLAIN-BARRE SYNDROME 77 0.0159
366 CUSHINGOID 51 0.0159
367 RESPIRATORY TRACT INFECTION VIRAL 37 0.0159
368 NEUTROPHIL COUNT DECREASED 643 0.0158
369 HAEMOLYSIS 121 0.0157
370 ENCEPHALOPATHY 384 0.0156
371 ADENOCARCINOMA OF COLON 29 0.0155
372 CANDIDA INFECTION 261 0.0154
373 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 158 0.0154
374 DISSEMINATED INTRAVASCULAR COAGULATION 216 0.0153
375 STEROID DIABETES 23 0.0153
376 PHARYNGEAL ULCERATION 20 0.0151
377 AUTOIMMUNE THYROIDITIS 57 0.0151
378 NEUTROPENIA 2047 0.0150
379 THROMBOCYTOPENIA 1680 0.0150
380 RECURRENT CANCER 61 0.0149
381 LICHENOID KERATOSIS 34 0.0149
382 HAEMATOCRIT DECREASED 293 0.0148
383 HYPERBILIRUBINAEMIA 153 0.0148
384 LUNG ADENOCARCINOMA 44 0.0146
385 OPPORTUNISTIC INFECTION 27 0.0146
386 CARDIOTOXICITY 130 0.0146
387 HYPOXIA 513 0.0146
388 GENERALISED OEDEMA 179 0.0144
389 MYELITIS TRANSVERSE 20 0.0142
390 SEPSIS 1576 0.0141
391 SQUAMOUS CELL CARCINOMA 131 0.0139
392 RESPIRATORY FAILURE 1013 0.0139
393 VACCINATION FAILURE 23 0.0138
394 FUNGAL INFECTION 461 0.0138
395 STAPHYLOCOCCUS TEST POSITIVE 29 0.0137
396 BRAIN HERNIATION 41 0.0137
397 PORTAL HYPERTENSION 42 0.0136
398 HYDROCEPHALUS 73 0.0134
399 MULTIPLE-DRUG RESISTANCE 41 0.0132
400 DRUG RESISTANCE 339 0.0132
401 STAPHYLOCOCCAL INFECTION 435 0.0132
402 HAEMOLYTIC ANAEMIA 117 0.0130
403 LUNG INFILTRATION 115 0.0130
404 HEPATIC NECROSIS 49 0.0130
405 HYPOPHOSPHATAEMIA 96 0.0130
406 LEFT VENTRICULAR DYSFUNCTION 87 0.0130
407 ENTEROCOLITIS 74 0.0128
408 HYPOPROTEINAEMIA 24 0.0126
409 METASTATIC MALIGNANT MELANOMA 29 0.0126
410 VITILIGO 29 0.0124
411 PLASMACYTOMA 23 0.0123
412 THERAPY PARTIAL RESPONDER 191 0.0122
413 CARDIAC TAMPONADE 58 0.0122
414 CLOSTRIDIUM DIFFICILE INFECTION 266 0.0122
415 PATHOGEN RESISTANCE 111 0.0122
416 DEVICE RELATED INFECTION 187 0.0121
417 NEUROLOGICAL SYMPTOM 69 0.0121
418 LUNG OPACITY 31 0.0118
419 PULMONARY TOXICITY 82 0.0116
420 LYMPH NODE PAIN 21 0.0113
421 SPLENOMEGALY 131 0.0112
422 ACTINIC KERATOSIS 29 0.0112
423 LYMPHADENOPATHY 395 0.0111
424 BASAL CELL CARCINOMA 174 0.0111
425 TOXIC ENCEPHALOPATHY 56 0.0110
426 MYELOSUPPRESSION 398 0.0110
427 RESPIRATORY DISTRESS 303 0.0110
428 PERICARDIAL EFFUSION 253 0.0109
429 CLOSTRIDIAL INFECTION 37 0.0109
430 CLOSTRIDIUM TEST POSITIVE 24 0.0109
431 HEPATOMEGALY 106 0.0108
432 CD4 LYMPHOCYTES DECREASED 23 0.0107
433 HEPATIC FAILURE 320 0.0106
434 BRAIN OEDEMA 134 0.0106
435 SUBDURAL HAEMORRHAGE 29 0.0106
436 COVID-19 PNEUMONIA 125 0.0106
437 HEPATOTOXICITY 230 0.0103
438 HYPERPHOSPHATAEMIA 22 0.0102
439 HEART RATE ABNORMAL 55 0.0099
440 INFECTION 1413 0.0098
441 THROMBOTIC THROMBOCYTOPENIC PURPURA 34 0.0096
442 OESOPHAGEAL CANDIDIASIS 38 0.0095
443 BLOOD LACTATE DEHYDROGENASE INCREASED 151 0.0095
444 HYPERVOLAEMIA 47 0.0095
445 HAEMOLYTIC URAEMIC SYNDROME 22 0.0095
446 INFLAMMATORY MARKER INCREASED 47 0.0095
447 PARESIS 21 0.0094
448 ENTERITIS 60 0.0094
449 FUNGAL SKIN INFECTION 37 0.0092
450 GASTROINTESTINAL INFECTION 82 0.0091
451 DISEASE PROGRESSION 1077 0.0091
452 PRODUCT USE IN UNAPPROVED INDICATION 2252 0.0091
453 BLOOD BILIRUBIN INCREASED 244 0.0090
454 DEMYELINATION 37 0.0090
455 SUSPECTED OFF LABEL USE 40 0.0088
456 RETINAL HAEMORRHAGE 63 0.0088
457 ATYPICAL PNEUMONIA 26 0.0087
458 PULMONARY TUBERCULOSIS 37 0.0087
459 PYREXIA 2965 0.0086
460 ACUTE RESPIRATORY FAILURE 164 0.0085
461 ASCITES 248 0.0084
462 HAEMORRHAGE INTRACRANIAL 126 0.0084
463 HAEMODYNAMIC INSTABILITY 64 0.0084
464 VASCULAR DEVICE INFECTION 38 0.0084
465 BONE MARROW DISORDER 25 0.0083
466 MENINGITIS 55 0.0082
467 C-REACTIVE PROTEIN INCREASED 296 0.0081
468 PLEURAL EFFUSION 494 0.0081
469 PLATELET COUNT DECREASED 857 0.0080
470 HYPERURICAEMIA 33 0.0080
471 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 21 0.0080
472 HYPERAMMONAEMIA 40 0.0080
473 PARONYCHIA 35 0.0080
474 BRONCHIOLITIS 28 0.0079
475 ORGAN FAILURE 32 0.0079
476 IMMUNOSUPPRESSION 70 0.0079
477 AGRANULOCYTOSIS 147 0.0079
478 SERUM SICKNESS 22 0.0079
479 GASTROINTESTINAL NECROSIS 23 0.0079
480 CARDIAC DYSFUNCTION 29 0.0078
481 CARDIOPULMONARY FAILURE 30 0.0077
482 ANOREXIA 99 0.0077
483 METABOLIC ENCEPHALOPATHY 23 0.0077
484 CARDIAC FAILURE ACUTE 51 0.0076
485 MYOSITIS 68 0.0076
486 VIRAL UPPER RESPIRATORY TRACT INFECTION 36 0.0076
487 OLIGURIA 47 0.0076
488 RASH MACULO-PAPULAR 168 0.0075
489 DUODENITIS 23 0.0075
490 CANDIDIASIS 30 0.0075
491 MALIGNANT MELANOMA 99 0.0074
492 VENOUS THROMBOSIS 29 0.0074
493 APHASIA 221 0.0073
494 BRONCHOPNEUMONIA 25 0.0073
495 NEPHROTIC SYNDROME 50 0.0073
496 GRANULOCYTOPENIA 41 0.0072
497 ATELECTASIS 69 0.0071
498 THERAPY NON-RESPONDER 321 0.0071
499 ACUTE PULMONARY OEDEMA 40 0.0071
500 STOMATITIS 431 0.0071
501 MALNUTRITION 79 0.0071
502 HYPERTRANSAMINASAEMIA 49 0.0070
503 RENAL TUBULAR NECROSIS 69 0.0070
504 NEOPLASM PROGRESSION 243 0.0070
505 WHITE BLOOD CELL COUNT DECREASED 756 0.0070
506 LEUKOPENIA 348 0.0070
507 FAILURE TO THRIVE 36 0.0069
508 CHRONIC MYELOID LEUKAEMIA 32 0.0069
509 NON-SMALL CELL LUNG CANCER 33 0.0069
510 MENTAL STATUS CHANGES 190 0.0068
511 BLOOD MAGNESIUM DECREASED 59 0.0068
512 NECROSIS 38 0.0068
513 NO THERAPEUTIC RESPONSE 83 0.0068
514 PNEUMONITIS 184 0.0068
515 SHOCK HAEMORRHAGIC 55 0.0067
516 CARDIOMYOPATHY 99 0.0067
517 COAGULOPATHY 111 0.0067
518 STATUS EPILEPTICUS 75 0.0066
519 ENDOCARDITIS 34 0.0066
520 PYELONEPHRITIS 57 0.0066
521 HYPERTHERMIA 50 0.0065
522 RENAL CELL CARCINOMA 32 0.0065
523 SKIN EROSION 21 0.0065
524 FIBROSIS 20 0.0065
525 PULSELESS ELECTRICAL ACTIVITY 27 0.0065
526 VIRAL INFECTION 214 0.0064
527 OESOPHAGITIS 70 0.0064
528 HYPERPYREXIA 27 0.0064
529 SCLERODERMA 23 0.0063
530 MALIGNANT NEOPLASM PROGRESSION 643 0.0063
531 AZOTAEMIA 25 0.0063
532 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 342 0.0062
533 MYOCARDITIS 71 0.0062
534 DISEASE RECURRENCE 294 0.0062
535 ACIDOSIS 47 0.0061
536 MALABSORPTION 32 0.0061
537 ESCHERICHIA URINARY TRACT INFECTION 26 0.0061
538 TACHYPNOEA 83 0.0061
539 ARTHRITIS BACTERIAL 25 0.0061
540 ACUTE KIDNEY INJURY 932 0.0061
541 HERPES ZOSTER 347 0.0060
542 ORAL DISORDER 44 0.0060
543 SKIN MASS 40 0.0060
544 ANAL ABSCESS 32 0.0059
545 BLOOD ALBUMIN DECREASED 47 0.0059
546 INTRACRANIAL PRESSURE INCREASED 33 0.0059
547 HYPOMAGNESAEMIA 82 0.0059
548 COLITIS 223 0.0059
549 CACHEXIA 30 0.0058
550 LEUKAEMIA 55 0.0058
551 HEPATIC FIBROSIS 20 0.0058
552 PERIPHERAL SENSORY NEUROPATHY 34 0.0058
553 TRANSAMINASES INCREASED 129 0.0058
554 HEPATIC LESION 25 0.0058
555 CONGESTIVE CARDIOMYOPATHY 24 0.0058
556 GASTROINTESTINAL INFLAMMATION 45 0.0057
557 OESOPHAGEAL ULCER 22 0.0057
558 NECROTISING FASCIITIS 20 0.0057
559 ANAEMIA 1078 0.0056
560 DYSGRAPHIA 37 0.0056
561 ILEUS PARALYTIC 25 0.0056
562 POLYNEUROPATHY 67 0.0056
563 DRUG TOXICITY 76 0.0056
564 HEPATIC ENCEPHALOPATHY 52 0.0056
565 CEREBRAL HAEMORRHAGE 198 0.0055
566 GAMMA-GLUTAMYLTRANSFERASE INCREASED 122 0.0055
567 BLOOD DISORDER 44 0.0055
568 HEMIPARESIS 93 0.0055
569 TOXIC EPIDERMAL NECROLYSIS 83 0.0055
570 ANURIA 47 0.0055
571 MOUTH HAEMORRHAGE 40 0.0055
572 HAEMATURIA 186 0.0054
573 STREPTOCOCCAL INFECTION 30 0.0054
574 LUNG NEOPLASM 23 0.0054
575 HAEMOGLOBIN DECREASED 552 0.0054
576 MENINGITIS ASEPTIC 24 0.0053
577 HYPOCALCAEMIA 101 0.0053
578 SKIN LESION 146 0.0053
579 NEOPLASM 61 0.0053
580 CHOLESTASIS 101 0.0053
581 DIARRHOEA HAEMORRHAGIC 49 0.0052
582 ASPARTATE AMINOTRANSFERASE INCREASED 278 0.0052
583 LUNG INFECTION 81 0.0052
584 PROTHROMBIN TIME PROLONGED 31 0.0052
585 OFF LABEL USE 4520 0.0052
586 EJECTION FRACTION DECREASED 80 0.0051
587 ATAXIA 61 0.0051
588 CORONAVIRUS INFECTION 33 0.0050
589 TRANSFUSION 52 0.0050
590 HEPATIC CYTOLYSIS 63 0.0049
591 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 25 0.0049
592 ILEUS 61 0.0049
593 BRONCHIECTASIS 33 0.0049
594 SUBDURAL HAEMATOMA 70 0.0049
595 HAEMODIALYSIS 41 0.0049
596 LUNG DISORDER 239 0.0049
597 ACUTE HEPATIC FAILURE 66 0.0048
598 HYDRONEPHROSIS 36 0.0048
599 HEPATITIS 123 0.0048
600 PURPURA 42 0.0047
601 METASTASIS 33 0.0046
602 ALANINE AMINOTRANSFERASE INCREASED 283 0.0046
603 METASTASES TO LYMPH NODES 31 0.0046
604 HYPOKALAEMIA 212 0.0046
605 RENAL FAILURE 606 0.0046
606 PNEUMOTHORAX 72 0.0045
607 PNEUMONIA 1469 0.0045
608 ADRENAL INSUFFICIENCY 55 0.0045
609 RENAL IMPAIRMENT 375 0.0045
610 ANGIOPATHY 25 0.0045
611 AUTOIMMUNE HEPATITIS 31 0.0045
612 HYPERTRIGLYCERIDAEMIA 26 0.0044
613 PULMONARY MASS 66 0.0044
614 BLOOD ALKALINE PHOSPHATASE INCREASED 110 0.0044
615 OSTEOPENIA 66 0.0043
616 FACIAL PARALYSIS 37 0.0043
617 TUBULOINTERSTITIAL NEPHRITIS 81 0.0043
618 PETECHIAE 45 0.0043
619 HYPOTENSION 862 0.0043
620 VISUAL FIELD DEFECT 31 0.0043
621 MYOPATHY 37 0.0043
622 DEPRESSED LEVEL OF CONSCIOUSNESS 169 0.0043
623 PULMONARY OEDEMA 191 0.0043
624 ATRIAL FLUTTER 34 0.0043
625 BREATH SOUNDS ABNORMAL 21 0.0043
626 RESPIRATORY DISORDER 127 0.0042
627 PERONEAL NERVE PALSY 24 0.0042
628 ONYCHOCLASIS 29 0.0042
629 TREATMENT FAILURE 349 0.0042
630 CHOLECYSTITIS 50 0.0042
631 SKIN INFECTION 47 0.0042
632 HEPATIC FUNCTION ABNORMAL 156 0.0042
633 EXERCISE TOLERANCE DECREASED 24 0.0042
634 NERVOUS SYSTEM DISORDER 128 0.0041
635 PULMONARY CONGESTION 54 0.0041
636 CELLULITIS 206 0.0041
637 CARDIAC FAILURE 328 0.0041
638 ELECTROLYTE IMBALANCE 47 0.0040
639 MOTOR DYSFUNCTION 41 0.0040
640 ALTERED STATE OF CONSCIOUSNESS 87 0.0040
641 AUTOIMMUNE DISORDER 39 0.0040
642 PARKINSONISM 39 0.0040
643 RESPIRATORY TRACT INFECTION 103 0.0040
644 RENAL FAILURE ACUTE 166 0.0039
645 MUSCLE TWITCHING 90 0.0039
646 HEPATOCELLULAR INJURY 55 0.0039
647 ECCHYMOSIS 26 0.0038
648 APPENDICITIS 35 0.0037
649 SHOCK 86 0.0037
650 ATRIAL FIBRILLATION 364 0.0037
651 PROCTALGIA 24 0.0037
652 SINUS TACHYCARDIA 53 0.0037
653 HYPERCALCAEMIA 46 0.0037
654 ODYNOPHAGIA 22 0.0037
655 PULMONARY HYPERTENSION 76 0.0036
656 ORAL CANDIDIASIS 48 0.0036
657 INTERSTITIAL LUNG DISEASE 176 0.0036
658 SUBARACHNOID HAEMORRHAGE 37 0.0036
659 PERICARDITIS 61 0.0036
660 CYSTITIS 115 0.0036
661 INTENTIONAL PRODUCT USE ISSUE 314 0.0036
662 TOXIC SKIN ERUPTION 36 0.0036
663 DUODENAL ULCER 25 0.0035
664 FLUID OVERLOAD 51 0.0035
665 CARDIOGENIC SHOCK 50 0.0035
666 APNOEA 27 0.0035
667 PNEUMONIA ASPIRATION 86 0.0034
668 ORAL HERPES 67 0.0034
669 CENTRAL NERVOUS SYSTEM LESION 47 0.0034
670 PLASMA CELL MYELOMA 133 0.0034
671 TACHYCARDIA 302 0.0034
672 HEMIPLEGIA 28 0.0034
673 URINE OUTPUT DECREASED 29 0.0033
674 MELAENA 73 0.0033
675 PULMONARY ARTERIAL HYPERTENSION 48 0.0033
676 WHITE BLOOD CELL COUNT ABNORMAL 21 0.0033
677 BLOOD UREA INCREASED 55 0.0033
678 LEUKOCYTOSIS 59 0.0033
679 OSTEONECROSIS 107 0.0033
680 PROTEINURIA 60 0.0032
681 UROSEPSIS 29 0.0031
682 INTESTINAL PERFORATION 35 0.0031
683 BLOOD CREATININE INCREASED 201 0.0031
684 ABSCESS 49 0.0031
685 JOINT EFFUSION 21 0.0030
686 LIVER FUNCTION TEST INCREASED 65 0.0030
687 DELIRIUM 105 0.0030
688 TOXICITY TO VARIOUS AGENTS 510 0.0030
689 GLOMERULAR FILTRATION RATE DECREASED 37 0.0030
690 EMBOLISM 25 0.0030
691 SENSORY LOSS 24 0.0030
692 EPILEPSY 90 0.0029
693 GASTROINTESTINAL HAEMORRHAGE 246 0.0029
694 UPPER RESPIRATORY TRACT INFECTION 135 0.0029
695 DERMATITIS BULLOUS 21 0.0029
696 LIVER DISORDER 128 0.0029
697 RASH PUSTULAR 21 0.0029
698 GASTROENTERITIS 42 0.0029
699 NEUROPATHY PERIPHERAL 272 0.0029
700 DISORIENTATION 113 0.0028
701 MYOCLONUS 34 0.0028
702 MOUTH ULCERATION 60 0.0028
703 HYPERGLYCAEMIA 103 0.0028
704 HAEMOPTYSIS 78 0.0028
705 HYPONATRAEMIA 157 0.0028
706 FOLLICULITIS 29 0.0028
707 RHINITIS 22 0.0027
708 CEREBRAL DISORDER 20 0.0027
709 DIPLOPIA 70 0.0027
710 SKIN HYPERPIGMENTATION 23 0.0027
711 FACE OEDEMA 45 0.0027
712 GENERALISED TONIC-CLONIC SEIZURE 44 0.0027
713 ASPIRATION 29 0.0026
714 OPTIC NEURITIS 24 0.0026
715 JAUNDICE 71 0.0026
716 HEPATIC STEATOSIS 49 0.0026
717 IMMUNODEFICIENCY 39 0.0026
718 HYPERTENSION 552 0.0026
719 CARDIOMEGALY 32 0.0026
720 BLINDNESS 105 0.0026
721 PRODUCTIVE COUGH 123 0.0026
722 VASCULITIS 30 0.0026
723 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 75 0.0026
724 SEIZURE 294 0.0025
725 DRUG ADMINISTRATION ERROR 77 0.0025
726 PHARYNGITIS 31 0.0025
727 PANCREATITIS ACUTE 56 0.0025
728 CHILLS 290 0.0025
729 CONFUSIONAL STATE 399 0.0025
730 COMA 117 0.0025
731 BLOOD COUNT ABNORMAL 37 0.0024
732 METABOLIC ACIDOSIS 78 0.0024
733 GASTRITIS 64 0.0024
734 CONJUNCTIVITIS 45 0.0024
735 BODY TEMPERATURE INCREASED 49 0.0024
736 GENERAL PHYSICAL HEALTH DETERIORATION 276 0.0024
737 INFUSION RELATED REACTION 158 0.0024
738 EYELID PTOSIS 24 0.0024
739 THERAPEUTIC RESPONSE DECREASED 143 0.0024
740 TOOTH INFECTION 31 0.0023
741 HYPOPHAGIA 60 0.0023
742 HEPATIC CIRRHOSIS 44 0.0023
743 VENTRICULAR FIBRILLATION 26 0.0023
744 DYSURIA 86 0.0023
745 CEREBRAL INFARCTION 57 0.0023
746 UPPER GASTROINTESTINAL HAEMORRHAGE 39 0.0023
747 LIVER FUNCTION TEST ABNORMAL 67 0.0023
748 DRUG INEFFECTIVE 3025 0.0023
749 DRUG-INDUCED LIVER INJURY 72 0.0023
750 CIRCULATORY COLLAPSE 39 0.0023
751 COVID-19 401 0.0023
752 CARDIAC ARREST 188 0.0023
753 IMMUNE SYSTEM DISORDER 30 0.0023
754 IMPAIRED GASTRIC EMPTYING 31 0.0023
755 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 53 0.0023
756 SKIN REACTION 31 0.0022
757 BRAIN INJURY 22 0.0022
758 ISCHAEMIC STROKE 39 0.0022
759 BLOOD PRESSURE DECREASED 143 0.0022
760 DRUG ERUPTION 38 0.0021
761 RED BLOOD CELL COUNT DECREASED 61 0.0021
762 BLINDNESS UNILATERAL 30 0.0021
763 SMALL INTESTINAL OBSTRUCTION 26 0.0021
764 WHITE BLOOD CELL COUNT INCREASED 81 0.0021
765 FULL BLOOD COUNT DECREASED 42 0.0021
766 METASTASES TO LIVER 36 0.0020
767 OEDEMA 110 0.0020
768 THROMBOSIS 162 0.0020
769 HAEMORRHAGE 208 0.0020
770 OBSTRUCTIVE AIRWAYS DISORDER 22 0.0020
771 NEUTROPHIL COUNT INCREASED 20 0.0020
772 PRODUCT USE ISSUE 367 0.0020
773 SKIN CANCER 42 0.0019
774 MITRAL VALVE INCOMPETENCE 22 0.0019
775 STEVENS-JOHNSON SYNDROME 43 0.0019
776 END STAGE RENAL DISEASE 35 0.0019
777 LIVER INJURY 47 0.0019
778 LOWER RESPIRATORY TRACT INFECTION 87 0.0019
779 RENAL DISORDER 89 0.0019
780 PULMONARY EMBOLISM 181 0.0019
781 METASTASES TO LUNG 22 0.0019
782 MUSCULAR WEAKNESS 216 0.0019
783 MASS 26 0.0019
784 REBOUND EFFECT 21 0.0019
785 HYPOTHYROIDISM 59 0.0018
786 HEPATIC ENZYME INCREASED 124 0.0018
787 COLON CANCER 27 0.0018
788 DEEP VEIN THROMBOSIS 117 0.0018
789 HYPERKALAEMIA 63 0.0018
790 CARDIO-RESPIRATORY ARREST 75 0.0018
791 METASTASES TO CENTRAL NERVOUS SYSTEM 23 0.0018
792 LUNG NEOPLASM MALIGNANT 73 0.0018
793 INFLAMMATION 91 0.0018
794 DIALYSIS 25 0.0018
795 COGNITIVE DISORDER 82 0.0018
796 BLOOD SODIUM DECREASED 33 0.0017
797 SINUSITIS 179 0.0017
798 MYDRIASIS 22 0.0017
799 NIGHT SWEATS 55 0.0017
800 OEDEMA PERIPHERAL 205 0.0017
801 BRADYCARDIA 89 0.0017
802 HYPERLIPIDAEMIA 20 0.0017
803 OXYGEN SATURATION DECREASED 94 0.0017
804 POST PROCEDURAL COMPLICATION 32 0.0017
805 CONVULSION 95 0.0017
806 DRUG INTOLERANCE 159 0.0016
807 FRACTURE 31 0.0016
808 DIARRHOEA 1048 0.0016
809 GASTROINTESTINAL DISORDER 144 0.0016
810 SLEEP APNOEA SYNDROME 30 0.0016
811 CARDIAC FAILURE CONGESTIVE 125 0.0016
812 ORTHOSTATIC HYPOTENSION 27 0.0015
813 UNRESPONSIVE TO STIMULI 40 0.0015
814 EOSINOPHILIA 27 0.0015
815 EAR INFECTION 41 0.0015
816 RASH PAPULAR 34 0.0015
817 PRODUCT PRESCRIBING ISSUE 33 0.0015
818 VENTRICULAR TACHYCARDIA 25 0.0015
819 LACTIC ACIDOSIS 49 0.0015
820 ABDOMINAL PAIN 351 0.0015
821 PERITONITIS 31 0.0015
822 BLOOD TRIGLYCERIDES INCREASED 26 0.0015
823 PULMONARY FIBROSIS 28 0.0015
824 DRUG LEVEL INCREASED 24 0.0014
825 URINARY TRACT INFECTION 247 0.0014
826 RASH ERYTHEMATOUS 69 0.0014
827 ANAPHYLACTIC SHOCK 37 0.0014
828 DYSPNOEA EXERTIONAL 54 0.0014
829 PALLOR 39 0.0014
830 DERMATITIS 30 0.0014
831 AGITATION 105 0.0014
832 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 101 0.0014
833 CONDITION AGGRAVATED 431 0.0014
834 DRUG EFFECT INCOMPLETE 51 0.0014
835 EPISTAXIS 105 0.0014
836 ELECTROCARDIOGRAM QT PROLONGED 50 0.0014
837 DYSARTHRIA 52 0.0014
838 URINARY RETENTION 46 0.0014
839 APATHY 20 0.0014
840 DEATH 1176 0.0014
841 ACUTE MYOCARDIAL INFARCTION 40 0.0014
842 CHRONIC KIDNEY DISEASE 102 0.0013
843 ORAL PAIN 30 0.0013
844 OSTEOMYELITIS 24 0.0013
845 LETHARGY 76 0.0013
846 DRUG INTERACTION 209 0.0013
847 CARDIAC DISORDER 121 0.0013
848 MENINGIOMA 20 0.0013
849 COUGH 359 0.0013
850 GASTROENTERITIS VIRAL 23 0.0013
851 HAEMATOMA 33 0.0013
852 NEOPLASM MALIGNANT 84 0.0013
853 PANCREATITIS 66 0.0012
854 CATARACT 74 0.0012
855 ILL-DEFINED DISORDER 74 0.0012
856 TREMOR 201 0.0012
857 VOMITING 569 0.0012
858 ARRHYTHMIA 56 0.0012
859 PHOTOPHOBIA 22 0.0012
860 INFLUENZA 129 0.0012
861 DECREASED APPETITE 266 0.0011
862 HAEMATEMESIS 29 0.0011
863 VISUAL ACUITY REDUCED 38 0.0011
864 RASH 498 0.0011
865 SKIN DISORDER 38 0.0011
866 FLUID RETENTION 57 0.0011
867 ANAPHYLACTIC REACTION 61 0.0011
868 RESPIRATORY ARREST 30 0.0011
869 NAUSEA 849 0.0011
870 OSTEOPOROSIS 44 0.0011
871 LOSS OF CONSCIOUSNESS 136 0.0011
872 PRODUCT ADMINISTRATION ERROR 21 0.0010
873 HALLUCINATION 76 0.0010
874 DYSPNOEA 569 0.0010
875 RASH GENERALISED 26 0.0010
876 NEURALGIA 24 0.0010
877 POLLAKIURIA 41 0.0010
878 LABORATORY TEST ABNORMAL 29 0.0010
879 RECTAL HAEMORRHAGE 42 0.0010
880 BONE PAIN 57 0.0010
881 ASTHENIA 365 0.0010
882 INCORRECT PRODUCT ADMINISTRATION DURATION 21 0.0010
883 WEIGHT DECREASED 270 0.0010
884 SKIN ULCER 25 0.0010
885 SKIN EXFOLIATION 80 0.0009
886 CHEST DISCOMFORT 96 0.0009
887 DEHYDRATION 124 0.0009
888 MYALGIA 158 0.0009
889 DYSPHAGIA 88 0.0009
890 HAEMATOCHEZIA 51 0.0009
891 BLISTER 51 0.0009
892 SOMNOLENCE 178 0.0009
893 URINARY INCONTINENCE 26 0.0009
894 DISTURBANCE IN ATTENTION 47 0.0009
895 SYNCOPE 86 0.0009
896 RHINORRHOEA 55 0.0009
897 OSTEONECROSIS OF JAW 21 0.0008
898 SPEECH DISORDER 44 0.0008
899 RHABDOMYOLYSIS 35 0.0008
900 DIVERTICULITIS 23 0.0008
901 MENTAL DISORDER 36 0.0008
902 DIABETES MELLITUS 63 0.0008
903 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 21 0.0008
904 MOVEMENT DISORDER 26 0.0008
905 ABDOMINAL DISTENSION 83 0.0008
906 BRONCHITIS 58 0.0008
907 HYPERSENSITIVITY 143 0.0008
908 RENAL INJURY 22 0.0007
909 DYSKINESIA 29 0.0007
910 ECZEMA 37 0.0007
911 VISUAL IMPAIRMENT 87 0.0007
912 CHEST PAIN 130 0.0007
913 CHOLELITHIASIS 23 0.0007
914 RASH PRURITIC 38 0.0007
915 IMPAIRED HEALING 23 0.0007
916 HEADACHE 439 0.0007
917 PARAESTHESIA 110 0.0007
918 FATIGUE 541 0.0007
919 TRANSIENT ISCHAEMIC ATTACK 23 0.0007
920 PSYCHOTIC DISORDER 20 0.0007
921 HEART RATE INCREASED 67 0.0007
922 ERYTHEMA 139 0.0007
923 MALAISE 282 0.0006
924 PROSTATE CANCER 51 0.0006
925 ARTHROPATHY 35 0.0006
926 ABDOMINAL PAIN UPPER 126 0.0006
927 BACK PAIN 141 0.0006
928 WEIGHT INCREASED 130 0.0006
929 RESTLESSNESS 21 0.0006
930 HYPOAESTHESIA 85 0.0006
931 BALANCE DISORDER 49 0.0006
932 INTESTINAL OBSTRUCTION 21 0.0006
933 VISION BLURRED 76 0.0006
934 OROPHARYNGEAL PAIN 50 0.0005
935 SWELLING FACE 35 0.0005
936 COLITIS ULCERATIVE 24 0.0005
937 NECK PAIN 30 0.0005
938 CEREBROVASCULAR ACCIDENT 88 0.0005
939 VERTIGO 31 0.0005
940 CONSTIPATION 108 0.0005
941 WHEEZING 29 0.0005
942 SWELLING 45 0.0005
943 DRY MOUTH 39 0.0005
944 EYE PAIN 27 0.0005
945 MEMORY IMPAIRMENT 64 0.0005
946 HYPERHIDROSIS 60 0.0005
947 ARTHRALGIA 193 0.0005
948 NASAL CONGESTION 27 0.0005
949 DYSPEPSIA 44 0.0004
950 AMNESIA 29 0.0004
951 DYSGEUSIA 31 0.0004
952 UNEVALUABLE EVENT 31 0.0004
953 DRY EYE 20 0.0004
954 MEDICATION ERROR 22 0.0004
955 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 20 0.0004
956 ARTHRITIS 29 0.0004
957 ALOPECIA 72 0.0004
958 PAIN 224 0.0004
959 PRURITUS 138 0.0004
960 GAIT DISTURBANCE 68 0.0004
961 FALL 118 0.0004
962 INTENTIONAL PRODUCT MISUSE 31 0.0004
963 CONTUSION 34 0.0004
964 EYE IRRITATION 20 0.0003
965 ADVERSE EVENT 32 0.0003
966 DIZZINESS 172 0.0003
967 INSOMNIA 87 0.0003
968 PALPITATIONS 38 0.0003
969 PAIN IN EXTREMITY 95 0.0003
970 NO ADVERSE EVENT 58 0.0003
971 URTICARIA 51 0.0003
972 DEPRESSION 67 0.0003
973 FLUSHING 29 0.0003
974 BLOOD PRESSURE INCREASED 42 0.0003
975 INFLUENZA LIKE ILLNESS 21 0.0003
976 MATERNAL EXPOSURE DURING PREGNANCY 22 0.0002
977 PERIPHERAL SWELLING 38 0.0002
978 MYOCARDIAL INFARCTION 42 0.0002
979 SUICIDAL IDEATION 22 0.0002
980 MUSCLE SPASMS 44 0.0002
981 MUSCULOSKELETAL STIFFNESS 21 0.0002
982 BREAST CANCER 21 0.0002
983 ABDOMINAL DISCOMFORT 36 0.0002
984 DRY SKIN 25 0.0002
985 ANXIETY 51 0.0002
986 BLOOD GLUCOSE INCREASED 29 0.0002
987 NASOPHARYNGITIS 24 0.0001
988 OVERDOSE 27 0.0001
989 FEELING ABNORMAL 22 0.0001